Intellia Therapeutics, Inc. (NASDAQ:NTLA) ranks among the best CRISPR stocks to buy. Citizens JMP reaffirmed its Market ...

The company recently announced the start of patient screening for a phase 3 trial, called HAELO, which will test a one-off 50mg dose of NTLA-2002 in around 60 HAE patients and is due to readout ...

In October, Intellia reported phase 2 results with NTLA-2002 – which is pitching to become the first approved in vivo CRISPR therapy – saying the results suggested it could offer a "functional ...

Acciones de Intellia Therapeutics Inc hoy: rentabilidad y valor bursátil de la acción. Consulte la cotización de Intellia Therapeutics Inc en bolsa (NASDAQ:NTLA) y su último precio: 10,74.

Editas Medicine, Inc. (NASDAQ:EDIT) ranks among the best CRISPR stocks to buy. At the European Hematology Association 2025 ...

Check out our NTLA stock chart to see a history of performance, current stock value, and a timeline of financial events & indicators for a full analysis today.

Intellia Therapeutics, Inc. (NTLA) key stats comparison: compare with other stocks by metrics: valuation, growth, profitability, momentum, EPS revisions, dividends ...

Stay up to date on how Intellia Therapeutics Inc (NTLA:XNAS) stock has performed compared to similar stocks in the same industry on a daily, quarterly, and monthly basis.

Intellia Therapeutics Inc. advanced stock charts by Barron's. View NTLA historical stock data and compare to other stocks, and exchanges.

Released March 15th, 2002, 'Resident Evil' stars Milla Jovovich, Michelle Rodriguez, Eric Mabius, James Purefoy The R movie has a runtime of about 1 hr 40 min, and received a user score of 66 (out ...